Sterling Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 17	Mar ' 16	Dec ' 14	Dec ' 13	Dec ' 12

Profit before tax

-616.80

-687.62

-631.16

-593.08

-516.54

Net cashflow-operating activity

0.95

67.03

255.89

171.87

811.25

Net cash used in investing activity

-49.28

-84.45

17.20

-314.82

-811.62

Netcash used in fin. activity

48.62

16.40

-272.92

142.60

-3.79

Net inc/dec in cash and equivlnt

0.29

-1.02

0.17

-0.35

-4.15

Cash and equivalnt begin of year

16.64

17.66

17.49

17.83

21.99

Cash and equivalnt end of year

16.93

16.64

17.66

17.49

17.83